Cytek Investor Presentation Deck slide image

Cytek Investor Presentation Deck

Growing Market Needs Require Advanced Cell Analysis 8 Flow cytometry used in clinical settings and provide new possibilities for novel drug development The Rise of Immuno-Oncology 8 Customers demand increased access to high parameter flow cytometry at both the high-end and low-end entry points Demands of Flow Cytometry Customers are Increasing Market is characterized by large, legacy players and a dearth of innovation, thus there is a large appetite for novel solutions Opportunity to Innovate a Market Suffering from Inertia The diagnostics sector has enjoyed a period of significant innovation, particularly within the fields of genomics and proteomics Clinical Diagnostics are Changing Drive adoption and application development of Cytek's FSP platform 24
View entire presentation